4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1)

4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1)

英文名称:4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1)
CAS号:2388520-36-1
分子式:C41H69ClN6O12
分子量:873.48
EINECS号:
Mol文件:2388520-36-1.mol
4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) 结构式

4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1) 用途与合成方法

TLR7/8 agonist 4 hydroxy-PEG10-acid hydrochloride (compound 9) 是抗体-活性分子偶联物的一部分,由 TLR7/8 激活剂 TLR7/8 agonist 4 (HY-139018) 和可降解的 ADC linker hydroxy-PEG10-acid (HY-133307) 连接而成。

4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1)供应商 更多

吉林省晟创生物科技有限责任公司
联系电话:13251734045; 13251734045
产品介绍:
中文名称:1-(4-(4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-8-yl)piperazin-1-yl)-3,6,9,12,15,18,21,24,27,30-decaoxatritriacontan-33-oic acid hydrochloride
英文名称:1-(4-(4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-8-yl)piperazin-1-yl)-3,6,9,12,15,18,21,24,27,30-decaoxatritriacontan-33-oic acid hydrochloride
CAS:2388520-36-1
纯度:>95%
包装信息:1g;5g
浙江珲达生物科技有限公司
联系电话:0571-89903022 18679456698
产品介绍:
英文名称:TLR7/8 agonist 4 hydroxy-PEG10-acid hydrochloride
CAS:2388520-36-1
纯度:>=98%
包装信息:10mg

最新发布供应信息

TLR7/8 Agonist 4 Hydroxy-PEG10-Acid Hydrochloride
杭州埃米尔生物技术有限公司 2026-10-07

"4,7,10,13,16,19,22,25,28,31-Decaoxatritriacontanoic acid, 33-[4-(4-amino-2-butyl-3H-imidazo[4,5-c]quinolin-8-yl)-1-piperazinyl]-, hydrochloride (1:1)"相关产品信息